Awakn Life Sciences

About:

Awakn Life Sciences is an ecosystem for psychedelic-based treatments.

Website: https://awaknlifesciences.com

Twitter/X: awakn_ls

Top Investors: Innovate UK, TD Veen, Mystic Ventures, Negev Capital, National Institute for Health Research

Description:

Awakn Life Sciences is a biotechnology company with clinical operations that develops and delivers psychedelic medicine to better treat addiction. Awakn's team consists of chemists, scientists, psychiatrists, and psychologists who are developing and advancing the next generation of psychedelic drugs, therapies, and enabling technologies to treat addiction.

Total Funding Amount:

$12.1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Toronto, Ontario, Canada

Founded Date:

2020-01-01

Founders:

Anthony Tennyson, Jonathan Held

Number of Employees:

101-250

Last Funding Date:

2024-04-19

IPO Status:

Public

Industries:

© 2025 bioDAO.ai